.svg)
The Hexa-LPS Index: Reading Your Gut's Endotoxin Signal
The Hexa-LPS Index is a focused microbiome readout that estimates the balance of hexa-acylated lipopolysaccharides — the lipid A forms known to robustly activate the TLR4 receptor — relative to less-inflammatory variants. Modern stool sequencing (16S rRNA or shotgun metagenomics) identifies which organisms and pathways are present, and bioinformatic models translate that community into a predicted share of strongly TLR4-activating LPS. Some labs complement this with host-response markers that reflect exposure to gut-derived endotoxin.
The number is a snapshot, not a fixed trait. Your microbiome shifts with diet, medications, illness, stress, and travel, so the index reflects the ecosystem you are feeding right now.
Why the Hexa-LPS Balance Is Worth Measuring
Gut microbes are in constant chemical conversation with your immune system, and LPS is one of the loudest molecules in that conversation. Hexa-acylated forms — the most potent TLR4 ligands — drive a stronger inflammatory tone than penta- or tetra-acylated variants. When the community tilts toward hexa-acylated producers, even routine events like a high-fat meal can generate a transient bump in circulating endotoxin signals.
People typically test for one of a few reasons: persistent low-grade symptoms that suggest immune reactivity (skin flares, post-meal fatigue, brain fog) where a gut-inflammation contribution is plausible; a recent disruption such as antibiotics, restrictive dieting, or chronic stress; or wanting a baseline ahead of dietary or lifestyle changes aimed at calming systemic inflammatory tone.
Who This Test Is Most Useful For
The Hexa-LPS Index is most informative when symptoms or history suggest gut-driven immune activation is in play:
- People with persistent bloating, food reactivity, or post-meal heaviness that doesn't track to a single trigger.
- Anyone recovering from antibiotics, a restrictive diet, or a long stretch of high stress, where the ecosystem may be re-equilibrating.
- People working on metabolic health — insulin sensitivity, lipids, body composition — where the gut-inflammation axis is part of the strategy.
- Anyone adding fermentable fibers, polyphenols, or fermented foods who wants to see how the ecosystem responds.
- People curious how their current eating pattern compares against reference populations for endotoxin signaling.
How to Read Your Index
Reports typically present an index or proportion reflecting the predicted share of hexa-acylated LPS capacity in your community, compared with a reference population. Many summaries also highlight the organisms and pathways pulling the index up or down. In general, a more balanced microbiome shows higher diversity, healthy representation of short-chain fatty acid producers, and a comparatively lower hexa-LPS signal. Communities enriched in certain Enterobacteriaceae tend to push the index higher. "Normal" varies by geography, age, and diet — two people can land in a resilient range through different microbial casts.
A balanced or optimal result usually points to efficient fermentation of fibers into short-chain fatty acids that nourish the lining, calm inflammatory signaling, and reinforce tight junctions. A more imbalanced reading — reduced diversity, loss of beneficial genera, and an elevated hexa-LPS index — suggests stronger baseline TLR4 activation and a community pattern that may track with symptoms like bloating, irregularity, or reactivity. It is not a diagnosis; it is a map of functional tendencies.
What Quietly Edits Your Hexa-LPS Index Result
Several variables can move the index without telling you something fundamental changed:
- Recent diet — a stretch of low fiber, heavy alcohol, or ultra-processed foods can shift the ecosystem within days.
- Antibiotics or other gut-active medications, which can flatten diversity for weeks to months.
- Travel, illness, and acute stress, which transiently reshuffle the community.
- Stool form and bowel transit, which influence sequencing readouts.
- Sample handling — collection timing and storage affect DNA recovery.
- Lab methodology — 16S, shotgun metagenomics, and qPCR panels produce different scales, so compare results over time within one lab.
What to Pair the Index With
The Hexa-LPS Index sharpens when read alongside other markers:
- Overall microbial diversity and the broader SCFA picture (acetate, butyrate, propionate capacity).
- Host-response markers such as LBP and sCD14, which reflect exposure to gut-derived endotoxin.
- Systemic inflammation markers like hs-CRP, to put the gut signal in a whole-body context.
- Metabolic markers — fasting glucose, A1C, lipids — for the gut-metabolism connection.
- A symptom and diet diary, which makes individual changes legible in the data over time.
What the Hexa-LPS Index Can and Can't Tell You
The Hexa-LPS Index can quantify how prepared your current microbiome is to generate strongly TLR4-activating endotoxin, flag patterns that may underlie low-grade inflammatory symptoms, and give you a baseline to retest after a meaningful change. It cannot measure circulating endotoxin in your blood, diagnose a disease, or predict outcomes on its own. Its real value is pattern recognition over time — watching how diet quality, sleep, stress management, and microbiome-aware choices shift the balance toward a calmer, more resilient gut-immune signal.
FAQs
The Hexa-LPS Index Test analyzes the genetic material of bacteria, fungi, and other microorganisms in stool to identify species diversity, relative abundance, and the functional potential of the microbiome.
Results provide an assessment of microbial balance and potential metabolic functions—what organisms are present and in what proportions—but they indicate microbial composition and balance, not the presence or diagnosis of specific diseases.
The hexa-lps index test is a simple at‑home stool collection using the small swab or vial provided in the kit: you collect a small amount of stool as directed, place it into the supplied tube or swab container, and seal it for return to the lab.
Maintain cleanliness to avoid contamination (wash hands before and after, avoid touching the collection tip), clearly label the sample with the required information (name, date/time), and follow the kit instructions and shipping guidelines exactly—these steps are essential to ensure accurate sequencing results.
Your Hexa‑LPS Index Test results can provide actionable insights into several aspects of gut and overall health: patterns associated with digestion (how well your microbiome is breaking down food), signs of intestinal and systemic inflammation, potential impacts on nutrient absorption, shifts in metabolic processes tied to microbial activity, and signals that relate to gut–brain communication (which can influence mood, sleep, and cognitive function).
These microbiome patterns can correlate with certain symptoms or risks but do not by themselves diagnose specific diseases; results should be interpreted as one piece of your health picture alongside clinical evaluation, laboratory tests, and medical history—discuss findings with your healthcare provider to determine appropriate next steps.
Next‑generation sequencing provides high-resolution microbial data that can detect and quantify many bacterial signatures underlying the Hexa‑LPS Index, but interpretation of Hexa‑LPS Index Test results is probabilistic rather than definitive—the index estimates likelihoods or relative shifts in LPS‑related microbial patterns, not absolute diagnoses. Technical accuracy depends on sample quality, laboratory processing and bioinformatic pipelines, so sequencing is powerful for detecting DNA signals but clinical interpretation requires caution.
Results reflect a snapshot in time and can change with recent diet, stress, illness or antibiotic use, so a single test may not represent long‑term status; correlation with symptoms, clinical history and, when appropriate, repeat or complementary testing improves reliability.
Many people test their hexa-lps index once per year to establish a baseline, or more frequently—every 3–6 months—if they are actively adjusting diet, taking probiotics, starting medications, or making other interventions that could affect gut-derived LPS levels.
More important than a single reading is tracking the hexa-lps index over time: compare sequential results to see trends and the effect of interventions, which gives far more useful information than one-off measurements.
Yes — microbial populations, including those that contribute to a hexa‑LPS index, can shift quite rapidly: short‑term perturbations such as changes in diet, antibiotics, illness, travel or stress can alter relative abundances within days. However, more stable community patterns and typical index values usually emerge only over weeks to months as transient fluctuations settle.
For meaningful comparisons, keep lifestyle and diet consistent before retesting: avoid introducing new medications, major dietary shifts, or significant travel immediately prior to sampling, and allow several weeks to months for the microbiome to stabilize so results reflect durable change rather than short‑lived variation.
References
- Anhê, F. F., Barra, N. G., Cavallari, J. F., Henriksbo, B. D., & Schertzer, J. D. (2021). Metabolic endotoxemia is dictated by the type of lipopolysaccharide. Cell Reports, 36(11), 109691. https://doi.org/10.1016/j.celrep.2021.109691
- Martirosyan, A., Ohne, Y., Degos, C., Gorvel, L., Moriyón, I., Oh, S., & Gorvel, J. P. (2013). Lipopolysaccharides with acylation defects potentiate TLR4 signaling and shape T cell responses. PLOS ONE, 8(2), e55117. https://doi.org/10.1371/journal.pone.0055117
- Mann, E. R., Lam, Y. K., & Uhlig, H. H. (2024). Short-chain fatty acids: Linking diet, the microbiome and immunity. Nature Reviews Immunology, 24(8), 577-595. https://doi.org/10.1038/s41577-024-01014-8
- Lynch, S. V., & Pedersen, O. (2016). The human intestinal microbiome in health and disease. New England Journal of Medicine, 375(24), 2369-2379. https://doi.org/10.1056/NEJMra1600266
- Allaband, C., McDonald, D., Vázquez-Baeza, Y., Minich, J. J., Tripathi, A., Brenner, D. A., Loomba, R., Smarr, L., Sandborn, W. J., Schnabl, B., Dorrestein, P., Zarrinpar, A., & Knight, R. (2019). Microbiome 101: Studying, analyzing, and interpreting gut microbiome data for clinicians. Clinical Gastroenterology and Hepatology, 17(2), 218-230. https://doi.org/10.1016/j.cgh.2018.09.017
.avif)
.svg)
.svg)
